2151 related articles for article (PubMed ID: 224073)
21. Correlation between the serum norethindrone (NET) levels attained after insertion of a silastic implant releasing norethindrone acetate and the endogenous hormones particularly progesterone.
Laumas V; Jain AK; Jha P; Rahman SA; Kumar D; Malik BK; Sarkar NN; Takkar D; Hingorani V; Laumas KR
Contraception; 1981 Feb; 23(2):211-25. PubMed ID: 6786828
[TBL] [Abstract][Full Text] [Related]
22. The effect of contraceptive steroids on hypothalamic-pituitary function.
Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
[TBL] [Abstract][Full Text] [Related]
23. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
Smith SK; Kirkman RJ; Arce BB; McNeilly AS; Loudon NB; Baird DT
Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162
[TBL] [Abstract][Full Text] [Related]
24. Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel.
Gaspard UJ; Romus MA; Gillain D; Duvivier J; Demey-Ponsart E; Franchimont P
Contraception; 1983 Jun; 27(6):577-90. PubMed ID: 6225622
[TBL] [Abstract][Full Text] [Related]
25. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
[TBL] [Abstract][Full Text] [Related]
26. Adrenocortical function of patients using oral contraceptives.
Kauppila A; Järvinen PA; Ylöstalo P; Reinilä M
Acta Obstet Gynecol Scand; 1974; 53(2):155-9. PubMed ID: 4362662
[TBL] [Abstract][Full Text] [Related]
27. The effects of ampicillin on oral contraceptive steroids in women.
Back DJ; Breckenridge AM; MacIver M; Orme M; Rowe PH; Staiger C; Thomas E; Tjia J
Br J Clin Pharmacol; 1982 Jul; 14(1):43-8. PubMed ID: 6809025
[TBL] [Abstract][Full Text] [Related]
28. Pituitary and ovarian function in women receiving hormonal contraception.
Cohen BL; Katz M
Contraception; 1979 Nov; 20(5):475-87. PubMed ID: 393456
[TBL] [Abstract][Full Text] [Related]
29. Serum gonadotropin and ovarian steroid levels in women during administration of a norethindrone-ethinylestradiol triphasic oral contraceptive.
Ling WY; Johnston DW; Lea RH; Bent AE; Scott JZ; Toews MR
Contraception; 1985 Oct; 32(4):367-75. PubMed ID: 3935373
[TBL] [Abstract][Full Text] [Related]
30. Serum norethindrone (NET) concentrations following intramuscular NET enanthate injection. Effect upon serum LH, FSH, estradiol and progesterone.
Goebelsmann U; Stanczyk FZ; Brenner PF; Goebelsmann AE; Gentzschein EK; Mishell DR
Contraception; 1979 Mar; 19(3):283-313. PubMed ID: 572279
[TBL] [Abstract][Full Text] [Related]
31. The effect of oral contraceptive treatment on the serum concentration of dehydroisoandrosterone sulfate.
Madden JD; Milewich L; Parker CR; Carr BR; Boyar RM; Mac Donald PC
Am J Obstet Gynecol; 1978 Oct; 132(4):380-4. PubMed ID: 152061
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function.
Scott JZ; Kletzky OA; Brenner PF; Mishell DR
Fertil Steril; 1978 Aug; 30(2):141-5. PubMed ID: 98356
[TBL] [Abstract][Full Text] [Related]
33. The effect of oral contraceptives on mononuclear cell cholesteryl ester hydrolase activity.
Hagemenas FC; Yatsu FM; Manaugh LC
Lipids; 1980 Jan; 15(1):39-44. PubMed ID: 7360009
[TBL] [Abstract][Full Text] [Related]
34. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
[TBL] [Abstract][Full Text] [Related]
35. Accumulation of ethinylestradiol in blood and endometrium of women taking oral contraceptives: the sequential therapy.
Cortés-Gallegos V; Carranco A; Sojo I; Navarrette M; Cervantes C; Parra A
Fertil Steril; 1979 Nov; 32(5):524-7. PubMed ID: 499582
[TBL] [Abstract][Full Text] [Related]
36. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
Lemay A; Faure N
J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711
[TBL] [Abstract][Full Text] [Related]
37. Ovulation inhibition following vaginal administration of pills containing norethindrone and mestranol.
Coutinho EM; Silva AR; Carreira C; Barbosa I
Contraception; 1984 Feb; 29(2):197-202. PubMed ID: 6723313
[TBL] [Abstract][Full Text] [Related]
38. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
39. Influence of oral contraceptives on integrated secretion of gonadotropins.
Dericks-Tan JS; Gudacker V; Taubert HD
Contraception; 1992 Oct; 46(4):369-77. PubMed ID: 1486775
[TBL] [Abstract][Full Text] [Related]
40. Hormonal effects of the 300 microgram norethisterone (NET) minipill. 3. Comparison of the short-term (2nd month) and medium-term (6th month) effects in 21 subjects.
Landgren BM; Lager S; Diczfalusy E
Contraception; 1981 Mar; 23(3):269-99. PubMed ID: 6786830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
